During the past decade, Kyungpook National University Chilgok Hospital conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 19 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 17 clinical trials were completed. i.e. 23.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyungpook National University Chilgok Hospital" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Janssen Research & Development, LLC" with 11 trials sponsored, "Pfizer" with 11 trials sponsored, "Daiichi Sankyo, Inc." with 6 trials sponsored and "Kyungpook National University Hospital" with 6 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyungpook National University Chilgok Hospital" #1 collaborator was "AstraZeneca" with 6 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 4 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Coalition for Epidemic Preparedness Innovations" with 3 trials as a collaborator and "Korean Cancer Study Group" with 3 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Kyungpook National University Chilgok Hospital" are "Ulcerative Colitis" (9 trials), "Gastric Cancer" (7 trials), "Breast Cancer" (6 trials), "Crohn's Disease" (4 trials) and "Urinary Bladder Neoplasms" (4 trials). Many other conditions were trialed in "Kyungpook National University Chilgok Hospital" in a lesser frequency.

Most popular intervention types in "Kyungpook National University Chilgok Hospital" are "Drug" (81 trials), "Other" (13 trials), "Biological" (12 trials), "Procedure" (6 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Paclitaxel" (8 trials), "Atezolizumab" (6 trials), "Capecitabine" (6 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Kyungpook National University Chilgok Hospital" are 90 trials for "All" genders, 9 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are 70 active trials in "Kyungpook National University Chilgok Hospital". 2 are not yet recruiting, 45 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Kyungpook National University Chilgok Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kyungpook National University Chilgok Hospital, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".